Notes - Consolidated Statement Of Cash Flows

K Pharma,Inc. - Filing #7269885

Concept 2024-01-01 to
2024-12-31
Notes - Consolidated statement of cash flows
Notes - Consolidated statement of cash flows
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet
Description of significant transactions not requiring use of cash or cash equivalents

※2 重要な非資金取引の内容

重要な資産除去債務の計上額は、「注記事項(資産除去債務関係)」をご参照下さい。

 

Talk to a Data Expert

Have a question? We'll get back to you promptly.